Table 3.
Degree of Achievement of Objectives at Six Months in Both Groups
| Objectives (nI/nC) | Intervention (n = 762) |
Control (n = 748) |
Adjustedγ Odds ratio |
Adjusted OR 95% CI |
p-value |
|---|---|---|---|---|---|
| Given up smoking (253/200) | 76.3 | 71.0 | 1.25 | 0.81-1.94 | 0.309 |
| BMI ≥ 25 kg/m2 (567/547) | |||||
| < 25 kg/m2 | 9.9 | 7.8 | 1.21 | 0.79-1.86 | 0. 373 |
| ⇓ BMI ≥ 10% | 7.4 | 6.8 | 1.15 | 0.72-1.84 | 0.564 |
| ⇓ BMI ≥ 5% | 25.0 | 19.7 | 1.31 | 0.98-1.76 | 0.068 |
| BMI ≥ 30 kg/m2 (212/209) | |||||
| < 30 kg/m2 | 25.9 | 24.9 | 1.04 | 0.66-1.63 | 0.860 |
| ⇓ BMI ≥ 10% | 11.3 | 10.5 | 1.15 | 0.61-2.17 | 0.666 |
| ⇓ BMI ≥ 5% | 32.1 | 27.8 | 1.26 | 0.82-1.93 | 0.300 |
| Changes in BMI (average) (kg/m2)* | - 0.5 | - 0.2 | 0.35* | 0.16-0.55* | < 0.001 |
| Changes in abdominal perimeter (average) (cm)* | - 1.6 | - 0.6 | 1.03* | 0.00-2.06* | 0.05 |
| Exercise 5 times/week | 29.4 | 23.4 | 1.29 | 1.02-1.64 | 0.033 |
| Exercise 3 times/week | 48.4 | 41.0 | 1.29 | 1.05-1.59 | 0.017 |
| Cholesterol < 175 md/dl | 64.7 | 56.5 | 1.46 | 1.17-1.81 | 0.001 |
| LDL < 100 mg/dl (70 in diabetic patients) | 47.9 | 44.8 | 1.09 | 0.87-1.35 | 0.449 |
| BP < 135/80 mmHg (130/80 in diabetic patients) | 46.7 | 42.4 | 1.14 | 0.91-1.41 | 0.253 |
| Taking of medication (percentage who take it on final visit, out of total given medication on discharge from hospital) | |||||
| Aspirin (712/698) | 97.5 | 96.0 | 1.54 | 0.84-2.83 | 0.161 |
| Clopidogrel (571/533) | 72.9 | 74.3 | 0.91 | 0.69-1.20 | 0.499 |
| Beta-blockers (621/590) | 94.4 | 94.6 | 0.93 | 0.56-1.54 | 0.769 |
| ACE-inhibitors (400/387) | 86.8 | 84.0 | 1.31 | 0.87-1.98 | 0.192 |
| Angiotensin receptor blocking agent Type II (ARA II) (86/97) | 84.9 | 86.6 | 0.83 | 0.35-1.95 | 0.664 |
| Statins (677/635) | 98.1 | 95.9 | 0.83 | 0.35-1.95 | 0.029 |
Results in intervention and control columns expressed as % of total number of patients affected by this objective as indicated in the first column, unless otherwise indicated
γ Differences in means (ANOVA model) or odds ratios [OR, logistic regression] adjusted for age group, education level, history of stroke, medication for cholesterol and tobacco consumption prior to admission, variables with statistical significant differences at baseline in the group of patients included in this analysis. Reference group for all estimates: control group). See interpretation of OR in the results section.
* In these continuous outcome variables, (changes in body mass index [BMI] and abdominal perimeter) the coefficients of the ANOVA model adjusted for the same variables, instead of odds ratios, are presented.
nI/nC: Number of patients in intervention/control groups on which the percentages presented are based when they are not the same as the total indicated in the corresponding column.
CI: Confidence interval